Phase I Trial of a Prophylactic HIV-1 DNA gag-pol-env-nef Vaccine in St. Petersburg, Russia

被引：0
|
作者：
Murashev, B. [1 ]
Nazarenko, O. [1 ]
Akulova, E. [1 ]
Verevochkin, S. [1 ]
Astanina, M. [1 ]
Krasnoselskih, T. [2 ]
Lioznov, D. [2 ]
Sokolovskiy, E. [2 ]
Kozlov, A. [3 ]
机构：
[1] State Res Inst Highly Pure Biopreparat, St Petersburg, Russia
[2] St Petersburg Pavlov State Med Univ, St Petersburg, Russia
[3] Biomed Ctr, St Petersburg, Russia
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2011年 / 27卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A76 / A77
页数：2
相关论文
共 50 条
  • [1] Phase I trial of a prophylactic HIV-1 gag-pol-env DNA plasmid vaccine with IL-12 or IL-15 DNA molecular adjuvants (HVTN 070)
    Parker, S.
    Elizaga, M.
    Kim, D.
    Metch, B.
    Allen, M.
    De Rosa, S.
    Hural, J.
    Torres, K.
    Boyer, J.
    Joseph, P.
    Weiner, D. B.
    Kalams, S.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A91 - A91
  • [2] HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
    Wild, J.
    Kostler, J.
    Bredl, S.
    Bockl, K.
    Kindsmueller, K.
    Wagner, R.
    RETROVIROLOGY, 2009, 6
  • [3] Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C
    Elena Gomez, Carmen
    Luis Najera, Jose
    Jimenez, Victoria
    Bieler, Kurt
    Wild, Jens
    Kostic, Linda
    Heidari, Shirin
    Chen, Margaret
    Frachette, Marie-Joelle
    Pantaleo, Giuseppe
    Wolf, Hans
    Liljestrom, Peter
    Wagner, Ralf
    Esteban, Mariano
    VACCINE, 2007, 25 (11) : 1969 - 1992
  • [4] Env-Specific Immunogenicity of Asian Mosaic HIV-1 Subtype AE/B gag/pol/env Combination and HIV-1 env Alone DNA Vaccine in BALB/c Mice
    Sirivichayakul, S.
    Buranapraditkun, S.
    Thantiworasit, P.
    Rosati, M.
    Felber, B.
    Pitakpolrat, P.
    Korber, B.
    Ruxrungtham, K.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A154 - A154
  • [5] Improvement of the immunogenicity of a HIV-1 clade C candidate vaccine increasing Gag, Pol, Nef and Env specific T-cell responses
    Wild, J.
    Koestler, J.
    Bredl, S.
    Boeckl, K.
    Wagner, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 17 - 17
  • [6] P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
    J Wild
    J Köstler
    S Bredl
    K Böckl
    K Kindsmüller
    R Wagner
    Retrovirology, 6
  • [7] Modulation of Immune Responses to HIV-1 Env and Gag-Pol-Nef Antigens by Selective Deletion of a Poxvirus Gene
    Garcia-Arriaza, J.
    Esteban, M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A150 - A150
  • [8] Host Genetic Determinants of T Cell Responses to the MRKAd5 HIV-1 gag/pol/nef Vaccine in the Step Trial
    Fellay, Jacques
    Frahm, Nicole
    Shianna, Kevin V.
    Cirulli, Elizabeth T.
    Casimiro, Danilo R.
    Robertson, Michael N.
    Haynes, Barton F.
    Geraghty, Daniel E.
    McElrath, M. Juliana
    Goldstein, David B.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (06): : 773 - 779
  • [9] Functional human immunodeficiency virus type 1 (HIV-1) gag-pol or HIV-1 Gag-Pol and Env expressed from a single rhabdovirus-based vaccine vector genome
    McGettigan, JP
    Naper, K
    Orenstein, J
    Koser, M
    McKenna, PM
    Schnell, MJ
    JOURNAL OF VIROLOGY, 2003, 77 (20) : 10889 - 10899
  • [10] Head-to-head comparison of immunogenicity and efficacy in macaques of MVA and NYVAC vectors expressing HIV-1 ENV and SIV GAG/POL/NEF
    Mooij, P.
    Balla-Jaghjoorsingh, S.
    Beenhakker, N.
    van Haaften, P.
    Baak, I.
    Nieuwenhuis, I.
    Gomez, C. E.
    Najera, J. L.
    Jimenez, M. V.
    Wagner, R.
    Esteban, M.
    Heeney, J. L.
    JOURNAL OF MEDICAL PRIMATOLOGY, 2007, 36 (4-5) : 329 - 329
12345